First Interstate Bank Vertex Pharmaceuticals Inc Transaction History

First Interstate Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$199.77 - $247.81 $36,757 - $45,597	-184 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $83,355 - $111,955	-500 Reduced 73.1%	184 $40,000
Q1 2019 May 02, 2019	BUY	$163.73 - $194.7 $30,126 - $35,824	184 Added 36.8%	684 $126,000
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $83,865 - $96,370	-500 Reduced 50.0%	500 $96,000
Q2 2018 Jul 27, 2018	SELL	$145.72 - $169.96 $7,286 - $8,498	-50 Reduced 4.76%	1,000 $170,000
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $155,536 - $170,352	1,050	1,050 $160,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.